Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

L. Ratner, D. Rauch, H. Abel, B. Caruso, A. Noy, S. K. Barta, S. Parekh, J. C. Ramos, R. Ambinder, A. Phillips, J. Harding, H. H. Baydoun, X. Cheng, S. Jacobson

Research output: Contribution to journalLetterpeer-review

26 Scopus citations
Original languageEnglish
Pages (from-to)e408
JournalBlood cancer journal
StatePublished - Mar 25 2016

Cite this